Prognostic Factors: From Clinical Parameters to New Biological Markers
作者： J. B. Sørensen , K. Østerlind
DOI: 10.1007/978-3-642-59824-1_1
关键词: Non small cell 、 Intensive care medicine 、 Lung cancer 、 Treatment options 、 Clin oncol 、 Treatment results 、 Clinical trial 、 Medicine
摘要: The current treatment results for lung cancer clearly call improved therapy and also careful selection of patients the options from which they are most likely to benefit. A detailed knowledge prognostic factors, meaning variables with a well established relation prognosis, is important achieving these goals. Any clinical trial must therefore include an assessment possible influence such factors on therapeutic result.
springer.com
sci-hub.st 参考文章(173)
World Health Organization, None, WHO Handbook for Reporting Results of Cancer Treatment International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine. ,vol. 38, pp. 481- 481 ,(1980) , 10.1080/09553008014551861
Kell Østerlind, Per Kragh Andersen, Mogens Hansen, Per Dombernowsky, Heine Høi Hansen, Determinants of complete remission induction and maintenance in chemotherapy with or without irradiation of small cell lung cancer. Cancer Research. ,vol. 47, pp. 2733- 2736 ,(1987)
H Pappot, N Brünner, J Grondahl-Hansen, D Francis, K Osterlind, p53 Protein in Non-Small Cell Lung Cancer as Quantitated by Enzyme-linked Immunosorbent Assay: Relation to Prognosis Clinical Cancer Research. ,vol. 2, pp. 155- 160 ,(1996)
Lisa Torney, David B. Weiner, Robert A. Robinson, Jeffrey A. Kern, David A. Schwartz, Mark I. Greene, Joanne E. Nordberg, p185neu Expression in Human Lung Adenocarcinomas Predicts Shortened Survival Cancer Research. ,vol. 50, pp. 5184- 5191 ,(1990)
Tetsuya Mitsudomi, John D. Minna, Adi F. Gazdar, Seth M. Steinberg, Harvey Pass, Ruby Phelps, James L. Mulshine, Herbert K. Oie, Jean Viallet, ras Gene Mutations in Non-Small Cell Lung Cancers Are Associated with Shortened Survival Irrespective of Treatment Intent Cancer Research. ,vol. 51, pp. 4999- 5002 ,(1991)
Lawrence H Einhorn, PJ Loehrer, SD Williams, S Meyers, T Gabrys, SR Nattan, R Woodburn, R Drasga, J Songer, W Fisher, None, Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 4, pp. 1037- 1043 ,(1986) , 10.1200/JCO.1986.4.7.1037
M P Dearing, S M Steinberg, R Phelps, M J Anderson, J L Mulshine, D C Ihde, B E Johnson, Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. Journal of Clinical Oncology. ,vol. 8, pp. 1042- 1049 ,(1990) , 10.1200/JCO.1990.8.6.1042
T P Miller, T T Chen, C A Coltman, R M O'Bryan, R B Vance, G B Weiss, W S Fletcher, R L Stephens, R B Livingston, Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study. Journal of Clinical Oncology. ,vol. 4, pp. 502- 508 ,(1986) , 10.1200/JCO.1986.4.4.502
Michihiro Fujino, Hirotoshi Dosaka-Akita, Masao Harada, Hiromitsu Hiroumi, Ichiro Kinoshita, Kenji Akie, Yoshikazu Kawakami, Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer Cancer. ,vol. 76, pp. 2457- 2463 ,(1995) , 10.1002/1097-0142(19951215)76:12<2457::AID-CNCR2820761209>3.0.CO;2-X
M Nishio, T Koshikawa, T Kuroishi, M Suyama, K Uchida, Y Takagi, O Washimi, T Sugiura, Y Ariyoshi, T Takahashi, R Ueda, T Takahashi, Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. Journal of Clinical Oncology. ,vol. 14, pp. 497- 502 ,(1996) , 10.1200/JCO.1996.14.2.497